UCSF OnCore Clinical Trial Management System
OnCore Upgrade to 2026.1 Coming on June 11, 2026
Helpful Resources for Features with 2026.1:
The following guidance documents have been updated and provided to support this upgrade, update your bookmarks as needed.
Key Highlights:
- Security: Accounts
- OnCore user accounts that are inactive for 180 days will be automatically deactivated and will require a Helpdesk ticket to reactivate
- If you need assistance re-activating your account, contact OnCore support: [email protected]
- Subject Visit Updates (CRA/Subjects Consoles):
- New All/None options for marking scheduled procedures as Missed or N/A
- Treatment Arm name now visible on the Subject Visit Update page
- Review the Subject Visit Tracking guide for steps and screenshots
- Reference List updates:
- Common Terminology Criteria for Adverse Events (CTCAE) v6.0 added for Adverse Event reporting to align with National Cancer Institute (NCI) requirements.
- CTCAE v6.0 has been added to the Coding Scheme options in PC Console/Management
- Review the Serious Adverse Events guide for steps and screenshots
- Sponsor Type “Industry” updated to “Industrial” per NCI guidelines and reflected within applicable reports.
- Common Terminology Criteria for Adverse Events (CTCAE) v6.0 added for Adverse Event reporting to align with National Cancer Institute (NCI) requirements.
- Invoices & Sponsor Payments (Financials Console):
- Increased character limit for invoice comments
- Review the Invoices and Sponsor Payments guide for steps and screenshots
- Improved filtering and search functionality
- See OnCore 2026.1 Upgrade Brief
- Increased character limit for invoice comments
- Enhanced OnCore-APeX interface now sends arm code details with the billing grid, eliminating manual mapping
- See OnCore 2026.1 Upgrade Brief
Questions?
Contact OnCore Support: [email protected]